Search Thermo Fisher Scientific
Search Thermo Fisher Scientific
Learn how to benefit from recent technology advances to successfully develop your bioprocess.
Hear about the latest advances in serum-free, chemically defined media.
Learn how some key early technology choices can positively impact your bioprocess development agility and time to clinic.
This webinar demonstrates the critical role of media and supplements in influencing protein quality attributes.
Listen to this on-demand webinar to hear about the design aspects of the Hyperforma S.U.B.
This webinar demonstrates the benefits of peptones and how they can be used to enhance process performance and consistently yield a high-quality product.
Discover valuable risk mitigation strategies addressing important issues such as integrity or particulates.
Discover the latest advances in the field of perfusion media performance.
Hear from our experts: A retrospective look at past Mycoplasma validation queries and responses
Watch this webinar and learn more about validation of a qPCR assay for residual host cell DNA quantitation.
Watch this video and learn about the unique features and advantages of our first single-use system specifically engineered for microbial fermentation.
Research and development, process development, and pilot plants involved in scale-up and technology transfer can face significant setbacks such as time and data loss due to a lack of efficient, traceable data transfer.
The quality of raw materials needs to be considered according to the stage of development of the cell or gene therapy.
In moving processes from bench to pilot and ultimately production fermentors, it is critical to have a reliable scaledown model.
As competition and growth in the biotherapeutic industry continues, the need to reduce cell line development costs and decrease time-to-market is more crucial.
Scaling up adherent cell culture can be a difficult process for many vaccine, cell therapy, gene therapy, and viral vector manufacturers
The manufacturing of plasmid DNA is becoming a supply bottleneck due to rapidly growing demand for various gene-targeting biotherapeutics
Find out more about the development of a novel residual DNA assay for HEK-293.
Improvements in single-use systems have allowed implementation of high-demand cultures in emerging bioprocess workflows.
Adherent cell cultures, such as those with Vero cells, are often more challenging than their suspension-based counterparts.
Improvements in single-use systems have allowed implementation of high-density cultures in emerging bioprocess workflows.
Access a targeted collection of scientific application notes, case studies, posters, white papers and more for bioprocessing: